✨ Free AI Report
NeurAxis, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview NeurAxis, Inc.
Research Preview

NeurAxis, Inc.: Business Overview, Financials & Competitive Analysis

NeurAxis is a medical technology company developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. The company's flagship technology is Percutaneo...

Analyst-debate audio for NeurAxis, Inc.

AskCyborg analysts argue the bull and bear cases for NeurAxis, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
NeurAxis, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
5/ 10Mixed

Cyborg Score thesis

Early-stage medical device company with validated technology and growing revenue, but limited scale and cash require careful...

Read the full analyst-debate transcript →
Industry Medical Devices & Neuromodulation
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: July 20, 2026
AI-Verified Research
30+ Page Report

Get the Latest NeurAxis, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

NeurAxis, Inc. Overview

Pro stress-test →

NeurAxis is a medical technology company developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. The company's flagship technology is Percutaneous Electrical Nerve Field Stimulation (PENFS), with its FDA-cleared IB-Stim device for functional abdominal pain associated with irritable bowel syndrome and functional dyspepsia in patients 8 years and older.

Strategic Profile

Pro stress-test →

NeurAxis demonstrated strong revenue growth of 27% in Q4 2025 to $968k and 33% for full year 2025 to $3.6M. Key commercial milestones include a Category I CPT code effective January 2026, a VA Federal Supply Schedule contract, and expanded FDA clearance for IB-Stim. The company is positioning itself as a focused player in the neuromodulation space targeting gastrointestinal disorders.

Competitive Landscape

Pro stress-test →

Competitors in the neuromodulation and medical device space include Akari Therapeutics, SeaStar Medical Holding, Rein Therapeutics, Lixte Biotechnology, and Fibrobiologics. NeurAxis competes in the specialty medical device market focused on gastrointestinal disorders with a targeted platform approach.

Industry Context

NeurAxis, Inc. operates in Medical Devices & Neuromodulation.

Key facts

Founded: 2023 · Headquarters: Carmel, Indiana · Revenue: $3.6M (2025) · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for NeurAxis, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when NeurAxis, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

SeaStar MedicalMedical device company in electromedical therapiesAkari TherapeuticsBiotechnology and medical device developmentRein TherapeuticsMedical technology company

Compare NeurAxis, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

NeurAxis, Inc. operates in Medical Devices & Neuromodulation. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices & Neuromodulation research →
NEW · MCP server

Ask your AI assistant about NeurAxis, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare NeurAxis, Inc. and its top competitor on Cyborg Score”
“What did NeurAxis, Inc. do this quarter?”
“Is NeurAxis, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does NeurAxis, Inc. do?+
NeurAxis is a medical technology company developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. The company's flagship technology is Percutaneo...
What is NeurAxis, Inc.'s Cyborg Score?+
NeurAxis, Inc. has a Cyborg Score of 5/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are NeurAxis, Inc.'s main competitors?+
Named competitors include SeaStar Medical, Akari Therapeutics, Rein Therapeutics. The full competitive landscape is in the AskCyborg report.
How can I get the full NeurAxis, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the NeurAxis, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track NeurAxis, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual